Experimental Hematology and Oncology Impact Factor, Indexing, Ranking

Experimental Hematology and Oncology (EHO) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal. and its abbreviated form is Exp Hematol Oncol.

Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings. Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews. With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Experimental Hematology and Oncology Journal is Exp Hematol Oncol.

The Ranking of the Journal in 2024 is 1427. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Journal's Impact Factor in 2024 is 7.3. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The Journal SCImago in 2024 is 1.908. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The Journal's H-Index in 2024 is 35. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Journal is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. Google Scholar
• 5. DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of the Journal is Professor Delong Liu, MD, PhD, New York Medical College, USA

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is £2290.00, $2990.00, €2590.00

Call for paper : The Journal invites original research contributions for consideration of publication in Experimental Hematology and Oncology journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Experimental Hematology and Oncology involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of Experimental Hematology and Oncology to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Experimental Hematology and Oncology guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago